Perrigo Company PLC at Piper Sandler Growth Frontiers Conference Transcript

Sep 12, 2023 / 03:00PM GMT

Good morning, everybody. Thank you so much for coming in. We're happy to have Perrigo with us today and for those of you who are unfamiliar with Perrigo, we use their product every day as consumers. Perrigo is a major player in the branded and the private label self-care space. They make products generic Ibuprofen, allergy meds, even dental floss. Anything you really use in your daily lives, they likely make. And today, we have with us the CEO, Patrick Lockwood-Taylor, who just recently joined the team about 2 months ago.

And then we have Eduardo Bezerra, the CFO. And then as well we have Brad Joseph from investor relations in the crowd. So thank you both, for being here and Patrick I would like to start with you. Before we really get into more details, you just joined Perrigo a couple of months ago. You came over from Bayer, can you tell us initially what excited you about the Perrigo opportunity and why you wanted to come over to Perrigo.

Patrick Lockwood-Taylor - Perrigo Company plc - President, CEO & Director

Very good. What

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot